Source: Manufacturing Chemist

Nestle Health Science: Nestl Health Science and IdB partner to bring VOWST to Europe

Nestlé Health Science and IdB Holding have signed a licensing agreement to seek EMA approval for VOWST, the only FDA-approved oral live biotherapeutic for recurrent C. diff prevention

Read full article »
Est. Annual Revenue
$5.0-10B
Est. Employees
10-50K
Anna Mohl's photo - CEO of Nestle Health Science

CEO

Anna Mohl

CEO Approval Rating

83/100

Read more